(Q35544350)

8 August 2017

1 reference

title

Immunization of patients with bleeding disorders (English)

1 reference

8 August 2017

0 references

M. Makris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511291

14 March 2024

C. P. Conlon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511291

14 March 2024

H. G. Watson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511291

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511291

14 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2516.2003.00819.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00819.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2516.2003.00819.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00819.X

14 March 2024

1 reference

8 August 2017

volume

9

1 reference

8 August 2017

issue

5

1 reference

8 August 2017

page(s)

541-546

1 reference

The importance of injecting vaccines into muscle. Different patients need different needle sizes

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00819.X

Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00819.X

Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00819.X

23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.2003.00819.X

Safety of intramuscular injection of hepatitis B vaccine in haemophiliacs

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00819.X

Risk of hepatitis A virus infection in persons with hemophilia receiving plasma-derived products

14 March 2024

3

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00819.X

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

14 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00819.X

Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV type 1 RNA and determinants of antibody response

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00819.X

Effect of influenza vaccination on disease progression among HIV-infected persons

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.2003.00819.X

14 March 2024

Identifiers

1 reference

8 August 2017

1 reference